Search

Displaying results 6031 - 6040 of 8696 in total
  1. Drug

    Fanapanel

    go.drugbank.com/drugs/DB12393
    Investigational

    Fanapanel has been investigated for the treatment of Visual Acuity.

  2. Drug

    Mizoribine

    go.drugbank.com/drugs/DB12617
    Investigational

    Mizoribine has been investigated for the treatment of Rheumatoid Arthritis.

  3. Drug

    Patidegib

    go.drugbank.com/drugs/DB12655
    Investigational

    Patidegib has been investigated for the treatment of Conventional Chondrosarcoma.

  4. Drug

    BMS-582949

    go.drugbank.com/drugs/DB12696
    Investigational

    BMS-582949 has been investigated for the treatment of Psoriasis.

  5. Drug

    Elesclomol

    go.drugbank.com/drugs/DB05719
    Investigational

    In preclinical models elesclomol showed potent killing of a broad range of cancer cell types at high doses, and an ability to strongly enhance the efficacy of certain chemotherapy agents, with minimal

  6. Drug

    MLN-977

    go.drugbank.com/drugs/DB05431
    Experimental

    MLN-977 is a small molecule compound that inhibits the production of leukotrienes, especially 5-lipoxygenase. It is developed by PharmaEngine to treat asthma and chronic obstructive pulmonary disease.

  7. Drug

    MD-0727

    go.drugbank.com/drugs/DB05948
    Investigational

    MD-0727 is a novel, potent cholesterol absorption inhibitor (CAI) under investigation for the treatment of hypercholesterolemia (high cholesterol.

  8. Drug

    Canertinib

    go.drugbank.com/drugs/DB05424
    Investigational

    Canertinib is a pan-erbB tyrosine kinase inhibitor which work against esophageal squamous cell carcinoma in vitro and in vivo.

  9. Drug

    Mecamylamine

    go.drugbank.com/drugs/DB00657
    ApprovedInvestigational

    A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more of...

    Categories: Antihypertensive Agents Indicated for Hypertension
  10. Drug

    Cannabidivarin

    go.drugbank.com/drugs/DB14050
    Investigational

    While the primary components of cannabis, CBD and THC, have been shown to modulate many of their physiological effects through their binding to the cannabinoid-1 (CB1R) and cannabinoid-2 (CB2R) receptors … In October 2017 CBDV was given orphan designation by the European Medicines Agency for use in Rett Syndrome [L2952] and again in February 2018 for treatment of Fragile X Syndrome [L2951].